Status:

COMPLETED

Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke

Lead Sponsor:

Pfizer

Conditions:

Healthy

Eligibility:

MALE

18-55 years

Phase:

PHASE1

Brief Summary

This is a single dose inpatient and outpatient study to test whether an effect on the ability of platelets to stick to white blood cells in subjects who smoke.

Eligibility Criteria

Inclusion

  • Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12?lead electrocardiogram (ECG).
  • Smoker of at least 1 pack or more of cigarettes per day (20 plus or minus 3 cigarettes) for more than 1 year as determined by history.

Exclusion

    Key Trial Info

    Start Date :

    April 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2008

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT03860506

    Start Date

    April 1 2008

    End Date

    July 1 2008

    Last Update

    March 4 2019

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

    Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke | DecenTrialz